Publication date: Oct 22, 2024
Mucormycosis is an invasive fungal infection caused by fungi of the order Mucorales. During the coronavirus disease 2019 (COVID-19), a rise in the number of COVID-19-associated mucormycosis (CAM) patients was reported globally. Cutaneous mucormycosis is the third most common presentation of mucormycosis. It is classified as primary cutaneous and secondary cutaneous mucormycosis. The secondary form is more common than the primary cutaneous; however, most reports and case series in the literature are that of primary cutaneous mucormycosis. We accounted a case series of eight patients of CAM with secondary cutaneous mucormycosis.
| Concepts | Keywords |
|---|---|
| Coronavirus | Adult |
| Fungi | Aged |
| Invasive | Antifungal Agents |
| Mucormycosis | Antifungal Agents |
| Primary | COVID-19 |
| Dermatomycoses | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Mucormycosis | |
| SARS-CoV-2 |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | Mucormycosis |
| disease | MESH | invasive fungal infection |
| disease | MESH | Dermatomycoses |
Original Article
(Visited 3 times, 1 visits today)